Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 212

1.

Dose-response analysis of effects of tibolone on climacteric symptoms.

Landgren MB, Bennink HJ, Helmond FA, Engelen S.

BJOG. 2002 Oct;109(10):1109-14.

2.
3.

The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.

Kroiss R, Fentiman IS, Helmond FA, Rymer J, Foidart JM, Bundred N, Mol-Arts M, Kubista E.

BJOG. 2005 Feb;112(2):228-33.

4.

Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.

Hudita D, Posea C, Ceausu I, Rusu M.

Eur Rev Med Pharmacol Sci. 2003 Sep-Oct;7(5):117-25.

PMID:
15214586
5.
7.

Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.

Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA; TOTAL Study Investigators Group.

BJOG. 2007 Dec;114(12):1522-9.

8.

Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.

Bai W, Henneicke-von Zepelin HH, Wang S, Zheng S, Liu J, Zhang Z, Geng L, Hu L, Jiao C, Liske E.

Maturitas. 2007 Sep 20;58(1):31-41. Epub 2007 Jun 22.

PMID:
17587516
9.

Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.

Bouchard P, Panay N, de Villiers TJ, Vincendon P, Bao W, Cheng RJ, Constantine G.

Climacteric. 2012 Feb;15(1):12-20. doi: 10.3109/13697137.2011.586445. Epub 2011 Nov 8.

PMID:
22066790
10.

Effects of tibolone and continuous combined conjugated equine estrogen/medroxyprogesterone acetate on the endometrium and vaginal bleeding: results of the OPAL study.

Langer RD, Landgren BM, Rymer J, Helmond FA; OPAL Investigators.

Am J Obstet Gynecol. 2006 Nov;195(5):1320-7. Epub 2006 Jul 26.

PMID:
16875644
11.

Effects of tibolone and continuous combined hormone replacement therapy on bleeding rates, quality of life and tolerability in postmenopausal women.

Huber J, Palacios S, Berglund L, Hänggi W, Sathanandan SM, Christau S, Helmond F.

BJOG. 2002 Aug;109(8):886-93.

12.

The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.

Buckler H, Al-Azzawi F; UK VR Multicentre Trial Group.

BJOG. 2003 Aug;110(8):753-9.

13.

The influence of tibolone on quality of life in postmenopausal women.

Meeuwsen IB, Samson MM, Duursma SA, Verhaar HJ.

Maturitas. 2002 Jan 30;41(1):35-43.

PMID:
11809341
14.

Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.

Sismondi P, Kimmig R, Kubista E, Biglia N, Egberts J, Mulder R, Planellas J, Moggio G, Mol-Arts M, Kenemans P.

Maturitas. 2011 Dec;70(4):365-72. doi: 10.1016/j.maturitas.2011.09.003. Epub 2011 Oct 26.

PMID:
22030384
15.

Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints.

Egarter C, Huber J, Leikermoser R, Haidbauer R, Pusch H, Fischl F, Putz M.

Maturitas. 1996 Feb;23(1):55-62.

PMID:
8861087
16.

Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.

Rymer J, Robinson J, Fogelman I.

Climacteric. 2002 Dec;5(4):390-8.

PMID:
12626219
17.
18.

A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness.

Christodoulakos GE, Botsis DS, Lambrinoudaki IV, Papagianni VD, Panoulis CP, Creatsa MG, Alexandrou AP, Augoulea AD, Dendrinos SG, Creatsas GC.

Maturitas. 2006 Mar 20;53(4):413-23. Epub 2005 Sep 2.

PMID:
16140483
19.
20.

[Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].

Bai WP, Wang SY, Liu JL, Geng L, Hu LN, Zhang ZL, Chen SL, Zheng SR.

Zhonghua Fu Chan Ke Za Zhi. 2009 Aug;44(8):597-600. Chinese.

PMID:
20003788
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk